Testing effectiveness (Phase 2)Study completedNCT01052480
What this trial is testing
Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza
Who this might be right for
Influenza AInfluenza B
National Institute of Allergy and Infectious Diseases (NIAID) 98